4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide compound with 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1);Abacin; Abactrim; Acuco; Alcorim F; Alfatrim; Andoprim; Anitrim; Antibiotic TMP-SMZ; Antrimox; Aop-Sulfatrim; Apo-Sulfatrim; BS; Bacdan; Bacidal; Bacin; Bacticel; Bactifor; Bactoprim; Bactramin; Bactrim; Bactrim DS; Bactrim Forte; Bactrimel; Baktar; Bencole; Bethaprim; Biosulten; Biseptol; Biseptol 480; Brifeseptol; Briscotrim; Bronquimucil; Centrim; Chemitrim; Chemotrim; Ciplin; Co-Trimoxazole; Co-Trimoxizole; Co-trimox; Colizole; Colizole DS; Comox; Conprim; Cotrim; Cotrim-Diolan; Cotrimel; Cotrimoxazol; Cotrumoxazole; Deprim; Diseptyl; Drylin; Duon; Duratrimet; Ectaprim; Entrim; Esbesul; Espectrin; Euctrim; Eusaprim; Exbesul; Fectrim; Fermagex; Fortrim; Futin; Gantaprim; Gantrim; Groseptol 480; Hulin; Ikaprim; Imexim; Intertrim; Isotrim; Kemoprim Forte; Kepinol; Kepinol forte; Lagatrim;
Cotrimoxazole is a fully characterized chemical compound used as a reference standard of API Cotrimoxazole. The standard offered is compliant with regulatory guidelines. Cotrimoxazole is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 8064-90-2
